Nesrin F Taha

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Systemic Lupus Erythematosus

Molecularly Imprinted

Neuropathic Pain

Top Venues

Drug development and industrial pharmacy

AAPS PharmSciTech

Pharmaceutical development and technology

national Research Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

national Research Center

Egypt

PHD :: Pharmaceutical Sciences

Publications

Nesrin F Taha, Laila H Emara
Convolution- and Deconvolution-Based Approaches for Prediction of Pharmacokinetic Parameters of Diltiazem Extended-Release Products in Flow-Through Cell Dissolution Tester. AAPS PharmSciTech 23 (6) (2022)
Maha F Emam, Nesrin F Taha, Nadia M Mursi, Laila Hassanian Emara
Preparation, characterization and in-Vitro/in-Vivo evaluation of meloxicam extruded pellets with enhanced bioavailability and stability. Drug development and industrial pharmacy 47 (1) (2020)
Nesrin F Taha, Maha F Emam, Laila Hassanian Emara
A novel combination of Soluplus®/Poloxamer for Meloxicam solid dispersions via hot melt extrusion for rapid onset of action. Part 2: comparative bioavailability and IVIVC. Drug development and industrial pharmacy 46 (8) (2020)
Laila Hassanian Emara, Ahmed Abd El-Rahman El-Ashmawy, Nesrin F Taha
Stability and bioavailability of diltiazem/polyethylene oxide matrix tablets. Pharmaceutical development and technology 23 (10) (2017)